A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions

La polysensibilisation médicamenteuse systémique existe-t-elle ?

(2012) M. Studer et al.   ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE

Fluindione and drug reaction with eosinophilia and systemic symptoms: an unrecognised adverse effect?

(2011) Amélie Daveluy et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Delayed drug hypersensitivity: models of T-cell stimulation

(2010) Jacqueline Adam et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Epicutaneous patch testing in drug hypersensitivity syndrome (DRESS)

(2010) Felicidade Santiago et al.   CONTACT DERMATITIS

Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): A Multiorgan Antiviral T Cell Response

(2010) D. Picard et al.   Science Translational Medicine

Propylthiouracil-induced DRESS syndrome confirmed by a positive patch test

(2009) Y.-M. Ye et al.   ALLERGY

Skin Testing in Delayed Reactions to Drugs

(2009) Annick Barbaud   IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA

A review of drug patch testing and implications for HIV clinicians

(2008) Neil H Shear et al.   AIDS

Carbamazepine-induced DRESS and HHV6 primary infection: The importance of skin tests

(2008) Karim Aouam et al.   EPILEPSIA

Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) Syndrome Induced by Celecoxib and Anti-tuberculosis Drugs

(2008) Joo Ho Lee et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

Drug-induced hypersensitivity syndrome: Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome induced by aspirin treatment of Kawasaki disease

(2008) Tamihiro Kawakami et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis

(2008) Wen-Hung Chung et al.   NATURE MEDICINE